SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-24-048619
Filing Date
2024-04-18
Accepted
2024-04-18 08:21:32
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B5 tm2412151d1_424b5.htm 424B5 566584
2 GRAPHIC lg_nrx-4clr.jpg GRAPHIC 44375
3 GRAPHIC tm2412151d1_424b5img001.jpg GRAPHIC 3278
4 GRAPHIC tm2412151d1_424b5img002.gif GRAPHIC 2832
5 GRAPHIC tm2412151d1_424b5img003.jpg GRAPHIC 2299
6 GRAPHIC tm2412151d1_424b5img004.jpg GRAPHIC 3869
  Complete submission text file 0001104659-24-048619.txt   646041
Mailing Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801
Business Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801 484-254-6134
NRX Pharmaceuticals, Inc. (Filer) CIK: 0001719406 (see all company filings)

IRS No.: 822844431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-265492 | Film No.: 24852921
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)